CURE SYNGAP1 Grants Program
The CURE SYNGAP1 Grants Program funds research to advance clinical trial readiness and treatment development for SYNGAP1-Related Disorders.
Funder: CURE SYNGAP1
Due Dates (Anticipated): August 2027 (Letter of Intent deadline, projected)
Funding Amounts: Seed grant: up to $25,000 (one time) | Trainee: up to $65,000/year | Investigator: up to $130,000/year | Clinical Network Support: variable
Summary: Supports research to advance clinical trial readiness and treatment development for SYNGAP1-Related Disorders.
Key Information: Indirect costs are not allowed; only direct costs will be funded.
Description
The CURE SYNGAP1 Grants Program funds laboratory-based researchers and clinicians working to accelerate clinical trial readiness and the development of effective treatments for SYNGAP1-Related Disorders (SRD). The program prioritizes projects that expand patient identification through genetics, address challenging behaviors, and deepen understanding of SYNGAP1 functions to guide precision medicine. Funding is available for a range of activities, from proof-of-concept studies to translational research and support for clinical networks.
